Last reviewed · How we verify
SIIL Live Attenuated Influenza Vaccine — Competitive Intelligence Brief
phase 3
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
SIIL Live Attenuated Influenza Vaccine (SIIL Live Attenuated Influenza Vaccine) — PATH. SIIL Live Attenuated Influenza Vaccine works by exposing the body to a weakened form of the influenza virus to stimulate an immune response.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SIIL Live Attenuated Influenza Vaccine TARGET | SIIL Live Attenuated Influenza Vaccine | PATH | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SIIL Live Attenuated Influenza Vaccine CI watch — RSS
- SIIL Live Attenuated Influenza Vaccine CI watch — Atom
- SIIL Live Attenuated Influenza Vaccine CI watch — JSON
- SIIL Live Attenuated Influenza Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). SIIL Live Attenuated Influenza Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/siil-live-attenuated-influenza-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab